001     169689
005     20240229133652.0
024 7 _ |a 10.1016/j.cell.2021.06.004
|2 doi
024 7 _ |a pmid:34214472
|2 pmid
024 7 _ |a 0092-8674
|2 ISSN
024 7 _ |a 1097-4172
|2 ISSN
024 7 _ |a altmetric:108511392
|2 altmetric
037 _ _ |a DKFZ-2021-01496
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Béziat, Vivien
|b 0
245 _ _ |a Humans with inherited T cell CD28 deficiency are susceptible to skin papillomaviruses but are otherwise healthy.
260 _ _ |a New York, NY
|c 2021
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1635318248_1489
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 184(14):3812-3828.e30
520 _ _ |a We study a patient with the human papilloma virus (HPV)-2-driven 'tree-man' phenotype and two relatives with unusually severe HPV4-driven warts. The giant horns form an HPV-2-driven multifocal benign epithelial tumor overexpressing viral oncogenes in the epidermis basal layer. The patients are unexpectedly homozygous for a private CD28 variant. They have no detectable CD28 on their T cells, with the exception of a small contingent of revertant memory CD4+ T cells. T cell development is barely affected, and T cells respond to CD3 and CD2, but not CD28, costimulation. Although the patients do not display HPV-2- and HPV-4-reactive CD4+ T cells in vitro, they make antibodies specific for both viruses in vivo. CD28-deficient mice are susceptible to cutaneous infections with the mouse papillomavirus MmuPV1. The control of HPV-2 and HPV-4 in keratinocytes is dependent on the T cell CD28 co-activation pathway. Surprisingly, human CD28-dependent T cell responses are largely redundant for protective immunity.
536 _ _ |a 316 - Infektionen, Entzündung und Krebs (POF4-316)
|0 G:(DE-HGF)POF4-316
|c POF4-316
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a CD28
|2 Other
650 _ 7 |a HPV
|2 Other
650 _ 7 |a T cell
|2 Other
650 _ 7 |a cutaneous horn
|2 Other
650 _ 7 |a immunodeficiency
|2 Other
650 _ 7 |a oncogene
|2 Other
650 _ 7 |a papillomavirus
|2 Other
650 _ 7 |a somatic reversion
|2 Other
650 _ 7 |a tree man syndrome
|2 Other
650 _ 7 |a wart
|2 Other
700 1 _ |a Rapaport, Franck
|b 1
700 1 _ |a Hu, Jiafen
|b 2
700 1 _ |a Titeux, Matthias
|b 3
700 1 _ |a Bonnet des Claustres, Mathilde
|b 4
700 1 _ |a Bourgey, Mathieu
|b 5
700 1 _ |a Griffin, Heather
|b 6
700 1 _ |a Bandet, Élise
|b 7
700 1 _ |a Ma, Cindy S
|b 8
700 1 _ |a Sherkat, Roya
|b 9
700 1 _ |a Rokni-Zadeh, Hassan
|b 10
700 1 _ |a Louis, David M
|b 11
700 1 _ |a Changi-Ashtiani, Majid
|b 12
700 1 _ |a Delmonte, Ottavia M
|b 13
700 1 _ |a Fukushima, Toshiaki
|b 14
700 1 _ |a Habib, Tanwir
|b 15
700 1 _ |a Guennoun, Andrea
|b 16
700 1 _ |a Khan, Taushif
|b 17
700 1 _ |a Bender, Noemi
|0 P:(DE-He78)540833b33724d8def638cce2f0b4e187
|b 18
|u dkfz
700 1 _ |a Rahman, Mahbuba
|b 19
700 1 _ |a About, Frédégonde
|b 20
700 1 _ |a Yang, Rui
|b 21
700 1 _ |a Rao, Geetha
|b 22
700 1 _ |a Rouzaud, Claire
|b 23
700 1 _ |a Li, Jingwei
|b 24
700 1 _ |a Shearer, Debra
|b 25
700 1 _ |a Balogh, Karla
|b 26
700 1 _ |a Al Ali, Fatima
|b 27
700 1 _ |a Ata, Manar
|b 28
700 1 _ |a Dabiri, Soroosh
|b 29
700 1 _ |a Momenilandi, Mana
|b 30
700 1 _ |a Nammour, Justine
|b 31
700 1 _ |a Alyanakian, Marie-Alexandra
|b 32
700 1 _ |a Leruez-Ville, Marianne
|b 33
700 1 _ |a Guenat, David
|b 34
700 1 _ |a Materna, Marie
|b 35
700 1 _ |a Marcot, Léa
|b 36
700 1 _ |a Vladikine, Natasha
|b 37
700 1 _ |a Soret, Christine
|b 38
700 1 _ |a Vahidnezhad, Hassan
|b 39
700 1 _ |a Youssefian, Leila
|b 40
700 1 _ |a Saeidian, Amir Hossein
|b 41
700 1 _ |a Uitto, Jouni
|b 42
700 1 _ |a Catherinot, Émilie
|b 43
700 1 _ |a Navabi, Shadi Sadat
|b 44
700 1 _ |a Zarhrate, Mohammed
|b 45
700 1 _ |a Woodley, David T
|b 46
700 1 _ |a Jeljeli, Mohamed
|b 47
700 1 _ |a Abraham, Thomas
|b 48
700 1 _ |a Belkaya, Serkan
|b 49
700 1 _ |a Lorenzo, Lazaro
|b 50
700 1 _ |a Rosain, Jérémie
|b 51
700 1 _ |a Bayat, Mousa
|b 52
700 1 _ |a Lanternier, Fanny
|b 53
700 1 _ |a Lortholary, Olivier
|b 54
700 1 _ |a Zakavi, Faramarz
|b 55
700 1 _ |a Gros, Philippe
|b 56
700 1 _ |a Orth, Gérard
|b 57
700 1 _ |a Abel, Laurent
|b 58
700 1 _ |a Prétet, Jean-Luc
|b 59
700 1 _ |a Fraitag, Sylvie
|b 60
700 1 _ |a Jouanguy, Emmanuelle
|b 61
700 1 _ |a Davis, Mark M
|b 62
700 1 _ |a Tangye, Stuart G
|b 63
700 1 _ |a Notarangelo, Luigi D
|b 64
700 1 _ |a Marr, Nico
|b 65
700 1 _ |a Waterboer, Tim
|0 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
|b 66
|u dkfz
700 1 _ |a Langlais, David
|b 67
700 1 _ |a Doorbar, John
|b 68
700 1 _ |a Hovnanian, Alain
|b 69
700 1 _ |a Christensen, Neil
|b 70
700 1 _ |a Bossuyt, Xavier
|b 71
700 1 _ |a Shahrooei, Mohammad
|b 72
700 1 _ |a Casanova, Jean-Laurent
|b 73
773 _ _ |a 10.1016/j.cell.2021.06.004
|g p. S0092867421007054
|0 PERI:(DE-600)2001951-8
|n 14
|p 3812-3828.e30
|t Cell
|v 184
|y 2021
|x 0092-8674
909 C O |p VDB
|o oai:inrepo02.dkfz.de:169689
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 18
|6 P:(DE-He78)540833b33724d8def638cce2f0b4e187
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 66
|6 P:(DE-He78)6b4ebb9791b983b5620c0caaf3468e30
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-316
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Infektionen, Entzündung und Krebs
|x 0
913 0 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-316
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-300
|4 G:(DE-HGF)POF
|v Infections and cancer
|x 0
914 1 _ |y 2021
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-02-03
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-03
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CELL : 2019
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-02-03
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-02-03
915 _ _ |a IF >= 30
|0 StatID:(DE-HGF)9930
|2 StatID
|b CELL : 2019
|d 2021-02-03
920 1 _ |0 I:(DE-He78)F022-20160331
|k F022
|l Infektionen und Krebs-Epidemiologie
|x 0
920 1 _ |0 I:(DE-He78)F020-20160331
|k F020
|l Infektionen und Krebs-Epidemiologie
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)F022-20160331
980 _ _ |a I:(DE-He78)F020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21